Genesys Wins the ‘Deal of the Year’ Award at 2024 CVCA Awards

Ontario Industry UpdatesOBIO News
Written By Arsheen Kaur

Genesys Capital won the CVCA 2024 ‘Deal of the Year’ award for their investment in Montreal, Quebec-headquartered Inversago Pharma. Genesys led Inversago’s $7-million Series A round in 2018 which led to a $1.4 billion CAD acquisition by Novo Nordisk in August 2023.

Arsheen Kaur
Previous

A.I. Vali Recognized Among Top 10 Healthcare Solutions Providers
Next

Mesosil Secures $2.2 Million to Develop Infection-Fighting Biomaterials for Medical Devices